WO2026061888 - DUAL CURING COMPOSITION
National phase entry is expected:
Publication Number
WO/2026/061888
Publication Date
26.03.2026
International Application No.
PCT/EP2025/075996
International Filing Date
12.09.2025
Title **
[English]
DUAL CURING COMPOSITION
[French]
COMPOSITION À DOUBLE DURCISSEMENT
Applicants **
HENKEL AG & CO. KGAA
Inventors
CHEN, Chunfu
Priority Data
24201358.9
19.09.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2231 | |
| EPO | Filing, Examination, Granting | 10470 | |
| Japan | Filing, Examination, Granting | 2279 | |
| South Korea | Filing, Examination, Granting | 2323 | |
| USA | Filing, Examination, Granting | 5340 |

Total:
22,643
Contact Us
Abstract[English]
alkaryl; c) at least one polyepoxide compound which does not possess a (meth)acrylate group; optionally d) at least one monoepoxide compound which does not possess a (meth)acrylate group; e) a curing agent consisting of one or more compounds which provide at least one epoxide reactive group; and, f) at least one cure accelerator, wherein the composition is characterized in that the molar ratio of epoxide-reactive groups to epoxide groups is from 0.6:1 to 1.2:1.[French]
; c) au moins un composé polyépoxyde qui ne possède pas de groupe (méth)acrylate; éventuellement d) au moins un composé monoépoxyde qui ne possède pas de groupe (méth)acrylate; e) un agent de durcissement consistant en un ou plusieurs composés qui fournissent au moins un groupe réactif époxyde; et, f) au moins un accélérateur de durcissement, la composition étant caractérisée en ce que le rapport molaire des groupes réactifs époxyde aux groupes époxyde va de 0,6:1 à 1,2:1.